Abstract:Ning Li, &ast Jia-Min Shao, &ast Ye Jiang, Chu-Han Wang, Si-Bo Li, De-Chao Wang, Wei-Ying Di Department of Neurology, Affiliated Hospital of Hebei University, Baoding, Hebei Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wei-Ying Di, Email Background: This study addresses the predictive modeling of Enlarged Perivascular Spaces (EPVS) in neuroradiology and neurology, focusing on their impact on Cerebral Small Vessel Disease (CSVD) and neurodegenerative disorders. Methods: A retrospective analysis was conducted on 587 neurology inpatients, utilizing LASSO regression for variable selection and logistic regression for model development. The study included comprehensive demographic, medical history, and laboratory data analyses. Results: The model identified key predictors of EPVS, including Age, Hypertension, Stroke, Lipoprotein a, Platelet Large Cell Ratio, Uric Acid, and Albumin to Globulin Ratio. The predictive nomogram demonstrated strong efficacy in EPVS risk assessment, validated through ROC curve analysis, calibration plots, and Decision Curve Analysis. Conclusion: The study presents a novel, robust EPVS predictive model, providing deeper insights into EPVS mechanisms and risk factors. It underscores the potential for early diagnosis and improved management strategies in neuro-radiology and neurology, highlighting the need for future research in diverse populations and longitudinal settings. Keywords: Enlarged Perivascular Spaces, cerebral small vessel disease, predictive model, risk factors, neuro-radiology, LASSO regression In the interdisciplinary domain of neuro-radiology and neurology, the significance of Enlarged Perivascular Spaces (EPVS) is increasingly recognized, 1,2 especially in relation to their impact on Cerebral Small Vessel Disease (CSVD) 2,3 and other neurodegenerative disorders. EPVS, commonly observed phenomena in brain MRI, traditionally considered benign manifestations of cerebral aging and small vessel changes, are now understood to be linked with complex conditions such as stroke, 4 cognitive impairment, Alzheimer's, and Parkinson's disease. 5–9 The unique morphology and distribution of EPVS in neuroimaging offer a distinct perspective for exploring cerebral microenvironments. Despite this growing recognition of their neuropathological importance, the clinical implications and mechanisms of EPVS remain elusive. 10,11 Notably, in clinical neurology, the absence of quantitative assessments and robust diagnostic predictive models for EPVS limits their utility in disease management and therapeutic decision-making. This study, through a retrospective analysis of 587 neurology inpatients, including CSVD patients and a control group, aims to bridge this gap. Incorporating a comprehensive array of 88 variables, including head MRI images, demographics, medical histories, and a spectrum of laboratory markers, we employ LASSO regression for key variable selection, followed by logistic regression modeling. The model is visualized using Nomograms and further validated through ROC, Calibration, and DCA curves to ensure accuracy and applicability. Our objective is to develop an accurate and practical diagnostic model for EPVS, utilizing a comprehensive statistical approach. As EPVS are increasingly recognized as indicators of underlying cerebral pathologies that may affect the progression and treatment of various neurodegenerative and vascular conditions, a robust predictive model is essential. Such a model would allow clinicians to identify patients at high risk of adverse outcomes earlier, enabling more targeted interventions. This advancement is expected to improve patient management significantly, highlighting the need for advanced diagnostic tools to address the complex presentations of EPVS. We anticipate that this model will enhance the diagnosis and treatment of CSVD and related conditions, offering novel insights and substantial contributions to neuroscience and geriatric medicine. This retrospective study, undertaken at a major hospital in Baoding, China, between January 2020 and June 2022, was dedicated to discovering imaging markers indicative of cerebral small vessel disease (CSVD). Comprehensive analysis of existing patient records was methodically conducted to ensure thorough data evaluation. Participants aged 55 older above who underwent complete cranial magnetic resonance imaging (MRI) scans were included. These scans encompassed T1-weighted axial, T2-weighted axial, FLAIR, and axial susceptibility-weighted imaging techniques. The inclusion criteria for CSVD were based on radiological criteria, including evidence of lacunar infarcts, white matter h -Abstract Truncated-

Comprehensive predictive model for cerebral microbleeds: integrating clinical and biochemical markers

Cerebral Microbleeds and Stroke Risk after Ischaemic Stroke or Transient Ischaemic Attack: a Pooled Analysis of Individual Patient Data from Cohort Studies.

Exploration of a Comprehensive Index for Predicting Cognitive Impairment in Patients with Cerebral Small Vessel Disease and White Matter Lesions

Risk Factor Analysis in Patients Exhibiting Cerebral Microbleeds and the Correlation with Cognitive Impairment

Quantitative assessments of white matter hyperintensities and plasma biomarkers can predict cognitive impairment and cerebral microbleeds in cerebral small vessel disease patients

Logistic regression model for predicting risk factors and contribution of cerebral microbleeds using renal function indicators

Automated quantification of cerebral microbleeds in susceptibility-weighted MRI: association with vascular risk factors, white matter hyperintensity burden, and cognitive function

Clinical Prediction Model for Screening Acute Ischemic Stroke Patients With More Than 10 Cerebral Microbleeds

The Clinical Risk Factors of Cerebral Microbleeds and Its Relationship with Cognitive Dysfunction

Development and validation of an interpretable machine learning model—Predicting mild cognitive impairment in a high-risk stroke population

Correlation analysis and predictive model construction of metabolic syndrome, complete blood count-derived inflammatory markers, and overall burden of cerebral small vessel disease

Development and validation of a nomogram predictive model for cognitive impairment in cerebral small vessel disease: a comprehensive retrospective analysis

Integrating clinical and biochemical markers: a novel nomogram for predicting lacunes in cerebral small vessel disease

Unraveling the Predictors of Enlarged Perivascular Spaces: A Comprehensive Logistic Regression Approach in Cerebral Small Vessel Disease

Prediction of subjective cognitive decline after corpus callosum infarction by an interpretable machine learning-derived early warning strategy

The Prevalence and Risk Factors of Cerebral Microbleeds: A Community-Based Study in China

Establishment and validation of a risk stratification model for stroke risk within three years in patients with cerebral small vessel disease using a combined MRI and machine learning algorithm

Risk factors of cerebral microbleeds in patients with ischemic cerebrovascular disease

Deep learning based on susceptibility-weighted MR sequence for detecting cerebral microbleeds and classifying cerebral small vessel disease

Mechanism research about the role of microbleeds for early cognitive impairment in small vascular disease

Association of cerebral microbleeds with risks of cognitive impairment and dementia: A systematic review and meta-analysis of prospective studies